This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Drug Delivery: Surveying The Global Competitive Landscape

NEW YORK, March 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drug Delivery: Surveying the Global Competitive Landscape http://www.reportlinker.com/p01120909/Drug-Delivery-Surveying-the-Global-Competitive-Landscape.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Drug Delivery:Surveying the Global Competitive Landscape Drug Delivery: Surveying the global competitive landscape is a new ( March 2013) richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies. The report covers all major technology areas including controlled-release, nucleic acid, nano-enabled and targeted delivery.

The importance of drug-delivery technology grows ever more apparent and commercial and pharma industry interest continues to build. The new biologic products which are coming to market are widening the demand for novel delivery targeted mechanisms. Controlled-release technologies continue to play a crucial role in a product's life-cycle and the pharma industry is able to extend patent protection and preserve revenues.

The emerging biosimilars market offers great potential for developers of targeted delivery as a range of high-value brands such as Roche's Herceptin and Avastin will be subject to patent challenges in the coming years. With many biosimilars planned or already in development around the world, the need for novel delivery mechanisms will increase.

This report provides you with key data for each company... Company Overview & Technology Focus Key Personnel Key Milestones Products/Technologies Research Activities Key Agreements & Alliances Financial Data (where available) Contact DetailsThe ability to readily assess the companies involved, compare areas of research interest, profile products being developed, identify strategic collaborations and evaluate performance/funding is key to understanding this market. In 716 information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape (published March 2013) evaluates companies large and small from multinationals to specialist development and technology organisations.

Related Publications

Drug Delivery Insight Whether your interest is commercial, financial, scientific or technological, no other business publication comes close to Drug Delivery Insight for providing such a comprehensive overview of the latest developments in every area of drug delivery. Available in print or updated regularly online.

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines and Partnerships This 3-volume 185-page report is essential for commercial business analysts, research planners and new product development specialists. Anyone who needs to understand the future outlook for, and competitive environment in, the global drug delivery market will benefit.

Drug Delivery Technologies: Advanced Oral & Parenteral This major 2-volume report is essential reading for everyone in the drug delivery field, from niche technology specialists in the investment community and the pharmaceutical industry.

Medical Device Companies Analysis A unique reporting service providing a complete appraisal of leading medical device companies worldwide, from 5-year financial review to analysis of significant strategic alliances and research portfolios. This report details some of the most exciting technology out there and the companies involved

Web access included at no additional cost! Analysis of 106 companies including... 3M Drug Delivery Systems Access Pharmaceuticals Inc Acrux Ltd Acura Pharmaceuticals Agile Therapeutics Alkermes Inc Allergy Therapeutics Aradigm Corporation Atlantic Pharmaceuticals Baxa Corporation Baxter International Inc Biosante Pharmaceuticals Inc Calando Pharmaceuticals Camurus AB Cell Therapeutics Inc Cephalon Debiopharm SA Delcath Systems Inc Depomed Inc Durect Corporation DUSA Pharmaceuticals Inc Echo Therapeutics Emisphere Technologies Inc Enzon Inc Ethypharm S/A Flamel Technologies Inc GenVec Gilead Sciences Hospira Immunogen Impax Laboratories Innocoll Technologies Inovio Pharmaceuticals InSite Vision Inc Intercell AG Light Sciences Oncology Mannkind Corporation Marina Biotech MedImmune Inc Moog Medical Devices Nanobiotix Nanotherapeutics Inc Nektar Therapeutics NovaDel Pharma Orexo Otsuka Holdings Pearl Therapeutics Phosphagenics Limited PolyTherics Ltd Seattle Genetics Skinvisible Inc SkyePharma Plc Soligenix Starpharma Tekmira Pharmaceuticals Corporation Unilife Valeant Pharmaceuticals Vectura Ltd Vical Inc Vivus Inc Zogenix Inc Zosano Pharma

CONTENTS3M DRUG DELIVERY SYSTEMS 1KEY PERSONNEL .1COMPANY OVERVIEW 1KEY MILESTONES 1PRODUCTS / TECHNOLOGIES .2AGREEMENTS 6KEY FINANCIAL DATA 7COMPETITION 7ACCESS PHARMACEUTICALS INC 9KEY PERSONNEL .9COMPANY OVERVIEW 9KEY MILESTONES 9PRODUCTS / TECHNOLOGIES 10RESEARCH ACTIVITIES .12AGREEMENTS .15KEY FINANCIAL DATA 17COMPETITION 17ACRUX LTD 19KEY PERSONNEL 19COMPANY OVERVIEW .19KEY MILESTONES 19PRODUCTS / TECHNOLOGIES 20RESEARCH ACTIVITIES .21AGREEMENTS .22KEY FINANCIAL DATA 22ACURA PHARMACEUTICALS 23KEY PERSONNEL 23COMPANY OVERVIEW .23KEY MILESTONES 23PRODUCTS / TECHNOLOGIES 23RESEARCH ACTIVITIES .25AGREEMENTS .26KEY FINANCIAL DATA 27COMPETITION 27AGILE THERAPEUTICS 29KEY PERSONNEL 29COMPANY OVERVIEW .29PRODUCTS / TECHNOLOGIES 29RESEARCH ACTIVITIES .30KEY FINANCIAL DATA 31COMPETITION 31ALKERMES INC 33KEY PERSONNEL 33COMPANY OVERVIEW .33KEY MILESTONES 33PRODUCTS / TECHNOLOGIES .34PRODUCTS / TECHNOLOGIES (Elan Drug Technologies) 36RESEARCH ACTIVITIES 39AGREEMENTS .45KEY FINANCIAL DATA 46COMPETITION 46ALLERGY THERAPEUTICS 47KEY PERSONNEL .47COMPANY OVERVIEW 47KEY MILESTONES 47PRODUCTS / TECHNOLOGIES .48RESEARCH ACTIVITIES 50AGREEMENTS 50KEY FINANCIAL DATA 51COMPETITION 51APRICUS BIOSCIENCES INC 53KEY PERSONNEL .53COMPANY OVERVIEW 53KEY MILESTONES 53PRODUCTS / TECHNOLOGIES .54RESEARCH ACTIVITIES 55AGREEMENTS 57KEY FINANCIAL DATA 58COMPETITION 59APTALIS PHARMA 61KEY PERSONNEL .61COMPANY OVERVIEW 61KEY MILESTONES 61PRODUCTS / TECHNOLOGIES .62AGREEMENTS 65KEY FINANCIAL DATA 65APTARGROUP .67KEY PERSONNEL .67COMPANY OVERVIEW 67KEY MILESTONES 67PRODUCTS / TECHNOLOGIES .67KEY FINANCIAL DATA 68COMPETITION 68ARADIGM CORPORATION 69KEY PERSONNEL .69COMPANY OVERVIEW 69KEY MILESTONES 69PRODUCTS / TECHNOLOGIES .70RESEARCH ACTIVITIES 71AGREEMENTS 72KEY FINANCIAL DATA 72COMPETITION 73ATLANTIC PHARMACEUTICALS 75KEY PERSONNEL .75COMPANY OVERVIEW 75KEY MILESTONES 75PRODUCTS / TECHNOLOGIES .75KEY FINANCIAL DATA 76COMPETITION 76BAXTER INTERNATIONAL INC 77KEY PERSONNEL .77COMPANY OVERVIEW 77KEY MILESTONES 77PRODUCTS / TECHNOLOGIES .78RESEARCH ACTIVITIES 86AGREEMENTS 87KEY FINANCIAL DATA 88COMPETITION 88BIND BIOSCIENCES 89KEY PERSONNEL .89COMPANY OVERVIEW 89PRODUCTS / TECHNOLOGIES .89RESEARCH ACTIVITIES 90AGREEMENTS 91KEY FINANCIAL DATA 91COMPETITION 91BIODELIVERY SCIENCES INTERNATIONAL 93KEY PERSONNEL .93COMPANY OVERVIEW 93KEY MILESTONES 93PRODUCTS / TECHNOLOGIES .94RESEARCH ACTIVITIES 97AGREEMENTS 97KEY FINANCIAL DATA 98ASSOCIATED COMPANIES 99COMPETITION 99BIOJECT MEDICAL TECHNOLOGIES INC 101KEY PERSONNEL 101COMPANY OVERVIEW .101KEY MILESTONE 101PRODUCTS / TECHNOLOGIES 101RESEARCH ACTIVITIES .103AGREEMENTS .104KEY FINANCIAL DATA 105COMPETITION 105BIO-PATH HOLDINGS 107KEY PERSONNEL 107COMPANY OVERVIEW .107KEY MILESTONES 107PRODUCTS / TECHNOLOGIES 107RESEARCH ACTIVITIES .109AGREEMENTS 110KEY FINANCIAL DATA .110COMPETITION .111BIOSANTE PHARMACEUTICALS INC 113KEY PERSONNEL 113COMPANY OVERVIEW 113KEY MILESTONES .113PRODUCTS / TECHNOLOGIES 114RESEARCH ACTIVITIES 117AGREEMENTS .120KEY FINANCIAL DATA 121COMPETITION 121CALANDO PHARMACEUTICALS .123KEY PERSONNEL 123COMPANY OVERVIEW .123KEY MILESTONES 123PRODUCTS / TECHNOLOGIES 123RESEARCH ACTIVITIES .125AGREEMENTS .125KEY FINANCIAL DATA 126CAMURUS AB 127KEY PERSONNEL 127COMPANY OVERVIEW .127KEY MILESTONES 127PRODUCTS / TECHNOLOGIES 128RESEARCH ACTIVITIES .130AGREEMENTS .131KEY FINANCIAL DATA 131CAREFUSION .133KEY PERSONNEL 133COMPANY OVERVIEW .133KEY MILESTONES 133PRODUCTS 134AGREEMENTS .137KEY FINANCIAL DATA 138COMPETITION 139CELATOR PHARMACEUTICALS INC 141KEY PERSONNEL 141COMPANY OVERVIEW .141KEY MILESTONES 141PRODUCTS / TECHNOLOGIES 142R&D ACTIVITIES 143AGREEMENTS .145KEY FINANCIAL DATA 145CELL THERAPEUTICS INC 147KEY PERSONNEL 147COMPANY OVERVIEW .147KEY MILESTONES 147PRODUCTS / TECHNOLOGIES 148RESEARCH ACTIVITIES .149AGREEMENTS .151KEY FINANCIAL DATA 152CEPHALON .153KEY PERSONNEL 153COMPANY OVERVIEW .153KEY MILESTONES 153PRODUCTS 154R&D ACTIVITIES 155AGREEMENTS .157KEY FINANCIAL DATA 159COMPETITION 159CIPHER PHARMACEUTICALS 161KEY PERSONNEL 161COMPANY OVERVIEW .161KEY MILESTONES 161PRODUCTS/TECHNOLOGIES 162R&D MILESTONES 163AGREEMENTS .163KEY FINANCIAL DATA 164 COLUMBIA LABORATORIES INC 165KEY PERSONNEL 165COMPANY OVERVIEW .165KEY MILESTONES 165PRODUCTS / TECHNOLOGIES .166RESEARCH ACTIVITIES .167AGREEMENTS .168KEY FINANCIAL DATA 169COMPETITION 170CONSORT MEDICAL PLC 171KEY PERSONNEL 171COMPANY OVERVIEW .171KEY MILESTONES 171PRODUCTS / TECHNOLOGIES 171RESEARCH ACTIVITIES .173AGREEMENTS .173KEY FINANCIAL DATA .174COMPETITION .174CORNERSTONE THERAPEUTICS .175KEY PERSONNEL 175COMPANY OVERVIEW .175KEY MILESTONES 175PRODUCTS 176RESEARCH ACTIVITIES .177AGREEMENTS .177KEY FINANCIAL DATA 179CYTIMMUNE SCIENCES .181KEY PERSONNEL 181COMPANY OVERVIEW .181PRODUCTS / TECHNOLOGIES 181RESEARCH ACTIVITIES .182AGREEMENTS .182KEY FINANCIAL DATA 182COMPETITION 183DEBIOPHARM SA 185KEY PERSONNEL 185COMPANY OVERVIEW .185KEY MILESTONES 185PRODUCTS / TECHNOLOGIES 186RESEARCH ACTIVITIES 187AGREEMENTS .189KEY FINANCIAL DATA 190ASSOCIATED COMPANIES 190DELCATH SYSTEMS INC .191KEY PERSONNEL 191COMPANY OVERVIEW .191KEY MILESTONES 191TECHNOLOGIES 192RESEARCH ACTIVITIES .193AGREEMENTS .195KEY FINANCIAL DATA 196COMPETITION 196DEPOMED INC .197KEY PERSONNEL 197COMPANY OVERVIEW .197KEY MILESTONES 197PRODUCTS / TECHNOLOGIES 198RESEARCH ACTIVITIES .199AGREEMENTS .200KEY FINANCIAL DATA 202COMPETITION 202DURECT CORPORATION 203KEY PERSONNEL 203COMPANY OVERVIEW .203KEY MILESTONES 203PRODUCTS / TECHNOLOGIES 204AGREEMENTS .208KEY FINANCIAL DATA 210ASSOCIATED COMPANIES 210COMPETITION 210DUSA PHARMACEUTICALS INC 211KEY PERSONNEL 211COMPANY OVERVIEW 211PRODUCTS / TECHNOLOGIES 211RESEARCH ACTIVITIES 212AGREEMENTS .213KEY FINANCIAL DATA 214COMPETITION 215ECHO THERAPEUTICS .217KEY PERSONNEL 217COMPANY OVERVIEW .217KEY MILESTONES 217PRODUCTS / TECHNOLOGIES 217RESEARCH ACTIVITIES .219AGREEMENTS .220KEY FINANCIAL DATA 221COMPETITION 221ELITE PHARMACEUTICALS INC .223KEY PERSONNEL 223COMPANY OVERVIEW .223KEY MILESTONES 223PRODUCTS / TECHNOLOGIES 224RESEARCH ACTIVITIES .224AGREEMENTS .225KEY FINANCIAL DATA 226COMPETITION 226EGEN INC 227KEY PERSONNEL 227COMPANY OVERVIEW .227PRODUCTS/TECHNOLOGIES 227RESEARCH ACTIVITIES .228AGREEMENTS .229KEY FINANCIAL DATA 230EMISPHERE TECHNOLOGIES INC . 231KEY PERSONNEL 231COMPANY OVERVIEW .231KEY MILESTONES 231PRODUCTS / TECHNOLOGIES 231AGREEMENTS .235KEY FINANCIAL DATA 235COMPETITION 236ENCAP DRUG DELIVERY 237KEY PERSONNEL 237COMPANY OVERVIEW .237PRODUCTS / TECHNOLOGIES 237AGREEMENTS .238KEY FINANCIAL DATA 239ENDO HEALTH SOLUTIONS 241KEY PERSONNEL 241COMPANY OVERVIEW .241KEY MILESTONES 241TECHNOLOGIES/PRODUCTS .242R&D MILESTONES (Endo) 247AGREEMENTS .249AGREEMENTS (Penwest) 250COMPETITION 251KEY FINANCIAL DATA 251ENDOCYTE 253KEY PERSONNEL 253COMPANY OVERVIEW .253KEY MILESTONES 253PRODUCTS / TECHNOLOGIES 254RESEARCH ACTIVITIES .255AGREEMENTS .257KEY FINANCIAL DATA 257ENZON INC 259KEY PERSONNEL 259COMPANY OVERVIEW .259KEY MILESTONES 259PRODUCTS / TECHNOLOGIES 260RESEARCH ACTIVITIES .261AGREEMENTS .264KEY FINANCIAL DATA 264COMPETITION 264EPEIUS BIOTECHNOLOGIES INC 267KEY PERSONNEL 267COMPANY OVERVIEW .267KEY MILESTONES 267PRODUCTS/TECHNOLOGIES 268RESEARCH ACTIVITIES .269KEY FINANCIAL DATA 270COMPETITION 270ETHYPHARM S/A 273KEY PERSONNEL 273COMPANY OVERVIEW .273KEY MILESTONES 273PRODUCTS / TECHNOLOGIES 273RESEARCH ACTIVITIES .276AGREEMENTS .276KEY FINANCIAL DATA 277FLAMEL TECHNOLOGIES INC .279KEY PERSONNEL 279COMPANY OVERVIEW .279KEY MILESTONES 279PRODUCTS / TECHNOLOGIES 279R&D ACTIVITIES 282AGREEMENTS .283KEY FINANCIAL DATA 284COMPETITION 284FZIOMED INC 285KEY PERSONNEL 285COMPANY OVERVIEW .285KEY MILESTONES 285PRODUCTS / TECHNOLOGIES 286RESEARCH ACTIVITIES .287KEY FINANCIAL DATA 288GENEREX BIOTECHNOLOGY CORPORATION .289KEY PERSONNEL 289COMPANY OVERVIEW .289KEY MILESTONES 289PRODUCTS / TECHNOLOGIES 290RESEARCH ACTIVITIES .291AGREEMENTS .295KEY FINANCIAL DATA 297COMPETITION 297GENVEC 299KEY PERSONNEL 299COMPANY OVERVIEW .299KEY MILESTONES 299PRODUCTS / TECHNOLOGIES 299RESEARCH ACTIVITIES .300AGREEMENTS .301KEY FINANCIAL DATA 302COMPETITION 302GILEAD SCIENCES .303KEY PERSONNEL 303COMPANY OVERVIEW .303KEY MILESTONES 303PRODUCTS / TECHNOLOGIES 304RESEARCH ACTIVITIES .307AGREEMENTS .313KEY FINANCIAL DATA 315HOSPIRA .317KEY PERSONNEL 317COMPANY OVERVIEW .317KEY MILESTONES 317PRODUCTS / TECHNOLOGIES 318RESEARCH ACTIVITIES .322AGREEMENTS .323KEY FINANCIAL DATA 324IMMUNOGEN 325KEY PERSONNEL 325COMPANY OVERVIEW .325KEY MILESTONES 325PRODUCTS / TECHNOLOGIES 325RESEARCH ACTIVITIES .326AGREEMENTS .329KEY FINANCIAL DATA 330IMPAX LABORATORIES 331KEY PERSONNEL 331COMPANY OVERVIEW .331KEY MILESTONES 331PRODUCTS / TECHNOLOGIES 332RESEARCH ACTIVITIES .334AGREEMENTS .335KEY FINANCIAL DATA 337COMPETITION 337INNOCOLL TECHNOLOGIES .339KEY PERSONNEL 339COMPANY OVERVIEW .339KEY MILESTONES 339PRODUCTS / TECHNOLOGIES 340RESEARCH ACTIVITIES .342AGREEMENTS .344KEY FINANCIAL DATA 344INOVIO PHARMACEUTICALS 345KEY PERSONNEL 345COMPANY OVERVIEW .345KEY MILESTONES 345TECHNOLOGIES / PRODUCTS 345RESEARCH ACTIVITIES .346AGREEMENTS .350KEY FINANCIAL DATA 352KEY COMPETITION .352INSITE VISION INC 353KEY PERSONNEL 353COMPANY OVERVIEW .353KEY MILESTONES 353PRODUCTS / TECHNOLOGIES 353RESEARCH ACTIVITIES .356AGREEMENTS .358KEY FINANCIAL DATA 359COMPETITION 359INSYS THERAPEUTICS .361KEY PERSONNEL 361COMPANY OVERVIEW .361KEY MILESTONES 361PRODUCTS / TECHNOLOGIES 362AGREEMENTS .364KEY FINANCIAL DATA 364INTELGENX CORPORATION .365KEY PERSONNEL 365COMPANY OVERVIEW .365KEY MILESTONES 365PRODUCTS / TECHNOLOGIES 366RESEARCH ACTIVITIES .367AGREEMENTS .368KEY FINANCIAL DATA 370COMPETITION 370INTERCELL AG . 371KEY PERSONNEL 371COMPANY OVERVIEW .371KEY MILESTONES 371PRODUCTS / TECHNOLOGIES 372RESEARCH ACTIVITIES 373AGREEMENTS 376KEY FINANCIAL DATA 377COMPETITION 377LAVIPHARM GROUP 379KEY PERSONNEL 379COMPANY OVERVIEW .379KEY MILESTONES 379PRODUCTS / TECHNOLOGIES 379AGREEMENTS .381KEY FINANCIAL DATA 382LIGHT SCIENCES ONCOLOGY .383KEY PERSONNEL 383COMPANY OVERVIEW .383PRODUCTS / TECHNOLOGIES 383RESEARCH ACTIVITIES .384AGREEMENTS .386KEY FINANCIAL DATA 386MANNKIND CORPORATION 387KEY PERSONNEL 387COMPANY OVERVIEW .387KEY MILESTONES 387PRODUCTS / TECHNOLOGIES 388RESEARCH ACTIVITIES .390AGREEMENTS .393KEY FINANCIAL DATA 394COMPETITION 394MARINA BIOTECH 397KEY PERSONNEL 397COMPANY OVERVIEW .397KEY MILESTONES 397PRODUCTS / TECHNOLOGIES 398RESEARCH ACTIVITIES .400AGREEMENTS .403KEY FINANCIAL DATA 405COMPETITION 405MEDIMMUNE INC .407KEY PERSONNEL 407COMPANY OVERVIEW .407KEY MILESTONES 407PRODUCTS / TECHNOLOGIES 408RESEARCH ACTIVITIES .409AGREEMENTS .410KEY FINANCIAL DATA .411COMPETITION 412MILESTONE SCIENTIFIC .413KEY PERSONNEL 413COMPANY BACKGROUND 413KEY MILESTONES 413PRODUCTS / TECHNOLOGIES 413AGREEMENTS .415KEY FINANCIAL DATA 416COMPETITION 417MOOG MEDICAL DEVICES .419KEY PERSONNEL 419COMPANY OVERVIEW .419KEY MILESTONES 419PRODUCTS / TECHNOLOGIES 419AGREEMENTS .420KEY FINANCIAL DATA 421NANOBIOTIX 423KEY PERSONNEL 423COMPANY OVERVIEW .423PRODUCTS / TECHNOLOGIES 423RESEARCH ACTIVITIES .424AGREEMENTS .424KEY FINANCIAL DATA 425NANOBIO CORPORATION .427KEY PERSONNEL 427COMPANY OVERVIEW .427KEY MILESTONES 427PRODUCTS / TECHNOLOGIES 427RESEARCH ACTIVITIES .428AGREEMENTS .430KEY FINANCIAL DATA 431NANOCARRIER 433KEY PERSONNEL 433COMPANY OVERVIEW .433PRODUCTS / TECHNOLOGIES 433RESEARCH ACTIVITIES .434AGREEMENTS .435KEY FINANCIAL DATA 437NANOTHERAPEUTICS INC 439KEY PERSONNEL 439COMPANY OVERVIEW .439KEY MILESTONES 439PRODUCTS / TECHNOLOGIES 440RESEARCH ACTIVITIES .443AGREEMENTS .445KEY FINANCIAL DATA 445NEKTAR THERAPEUTICS 447KEY PERSONNEL 447COMPANY OVERVIEW .447KEY MILESTONES 447PRODUCTS / TECHNOLOGIES 448RESEARCH ACTIVITIES .449AGREEMENTS .454KEY FINANCIAL DATA 455ASSOCIATED COMPANIES 455COMPETITION 456NEUROGESX .457KEY PERSONNEL 457COMPANY OVERVIEW .457KEY MILESTONES 457PRODUCTS / TECHNOLOGIES 458RESEARCH STRATEGY 458AGREEMENTS .459KEY FINANCIAL DATA 459COMPETITION 459NOVADEL PHARMA .461KEY PERSONNEL 461COMPANY OVERVIEW .461KEY MILESTONES 461PRODUCTS / TECHNOLOGIES 461RESEARCH ACTIVITIES .462AGREEMENTS .464KEY FINANCIAL DATA 465COMPETITION 465NOVEN PHARMACEUTICALS 467KEY PERSONNEL 467COMPANY OVERVIEW .467KEY MILESTONES 467PRODUCTS / TECHNOLOGIES 468RESEARCH ACTIVITIES .469AGREEMENTS .470KEY FINANCIAL DATA 470COMPETITION 471OCTOPLUS .473KEY PERSONNEL 473COMPANY OVERVIEW .473KEY MILESTONES 473PRODUCTS / TECHNOLOGIES 473AGREEMENTS .476KEY FINANCIAL DATA 478OREXO 479KEY PERSONNEL 479COMPANY OVERVIEW .479KEY MILESTONES 479PRODUCTS / TECHNOLOGIES 481RESEARCH ACTIVITIES .483AGREEMENTS .487KEY FINANCIAL DATA 488COMPETITION 488OTSUKA HOLDINGS 489KEY PERSONNEL 489COMPANY OVERVIEW .489KEY MILESTONES 489PRODUCTS / TECHNOLOGIES 490RESEARCH ACTIVITIES .494AGREEMENTS 497KEY FINANCIAL DATA 498PACIRA PHARMACEUTICALS INC .501KEY PERSONNEL 501COMPANY OVERVIEW .501KEY MILESTONES 501PRODUCTS / TECHNOLOGIES 502RESEARCH ACTIVITIES .503AGREEMENTS .505KEY FINANCIAL DATA 506COMPETITION 506PCI BIOTECH 507KEY PERSONNEL 507COMPANY OVERVIEW .507KEY MILESTONES 507PRODUCTS / TECHNOLOGIES 507RESEARCH ACTIVITIES .508AGREEMENTS .509KEY FINANCIAL DATA 509PEARL THERAPEUTICS 511KEY PERSONNEL 511COMPANY OVERVIEW 511PRODUCTS / TECHNOLOGIES 511RESEARCH STRATEGY 513KEY FINANCIAL DATA 515PHOSPHAGENICS LIMITED 517KEY PERSONNEL 517COMPANY OVERVIEW .517KEY MILESTONES 517TECHNOLOGIES / PRODUCTS 517RESEARCH ACTIVITIES .520AGREEMENTS .521FINANCIALS .522PHOTOCURE ASA .523KEY PERSONNEL 523COMPANY OVERVIEW .523KEY MILESTONES 523PRODUCTS / TECHNOLOGIES 524RESEARCH ACTIVITIES .525AGREEMENTS .528KEY FINANCIAL DATA 528ASSOCIATED COMPANIES 528POLYTHERICS LTD 529KEY PERSONNEL 529COMPANY OVERVIEW .529KEY MILESTONES 529PRODUCTS / TECHNOLOGIES 529AGREEMENTS .531KEY FINANCIAL DATA 533pSIVIDA 535KEY PERSONNEL 535COMPANY OVERVIEW .535KEY MILESTONES 535TECHNOLOGIES / PRODUCTS 536RESEARCH ACTIVITIES .537AGREEMENTS .540KEY FINANCIAL DATA 542COMPETITION 542QLT 543KEY PERSONNEL 543COMPANY OVERVIEW .543KEY MILESTONES 543PRODUCTS / TECHNOLOGIES 544RESEARCH ACTIVITIES .545AGREEMENTS .547KEY FINANCIAL DATA 548COMPETITION 548QUEST PHARMATECH .551KEY PERSONNEL 551COMPANY OVERVIEW .551KEY MILESTONES 551PRODUCTS / TECHNOLOGIES 551RESEARCH ACTIVITIES .552AGREEMENTS .553KEY FINANCIAL DATA 554RAPTOR PHARMACEUTICALS 555KEY PERSONNEL 555COMPANY OVERVIEW .555KEY MILESTONES 555PRODUCTS / TECHNOLOGIES 556RESEARCH ACTIVITIES .558AGREEMENTS .562KEY FINANCIAL DATA 563COMPETITION 563RETRACTABLE TECHNOLOGIES INC 567KEY PERSONNEL 567COMPANY OVERVIEW .567PRODUCTS / TECHNOLOGIES 567AGREEMENTS .569LITIGATION UPDATE 569KEY FINANCIAL DATA 569COMPETITION 569SAVARA PHARMACEUTICALS INC 571KEY PERSONNEL 571COMPANY OVERVIEW .571KEY MILESTONES 571PRODUCTS / TECHNOLOGIES 571RESEARCH ACTIVITIES .572KEY FINANCIAL DATA 572SCOLR PHARMA INC 573KEY PERSONNEL 573COMPANY OVERVIEW .573KEY MILESTONES 573PRODUCTS / TECHNOLOGIES 573RESEARCH ACTIVITIES .574AGREEMENTS 575KEY FINANCIAL DATA 576COMPETITION 576 SEATTLE GENETICS .577KEY PERSONNEL 577COMPANY OVERVIEW .577KEY MILESTONES 577PRODUCTS / TECHNOLOGIES 578RESEARCH ACTIVITIES .579AGREEMENTS .583KEY FINANCIAL DATA 584COMPETITION 585SILENCE THERAPEUTICS 587KEY PERSONNEL 587COMPANY OVERVIEW .587PRODUCTS / TECHNOLOGIES 587RESEARCH ACTIVITIES .588AGREEMENTS .590KEY FINANCIAL DATA 591SKINVISIBLE INC 593KEY PERSONNEL 593COMPANY OVERVIEW .593KEY MILESTONES 593PRODUCTS / TECHNOLOGIES 593RESEARCH ACTIVITIES .594AGREEMENTS .596KEY FINANCIAL DATA 597COMPETITION 597SKYEPHARMA PLC 599KEY PERSONNEL 599COMPANY OVERVIEW .599KEY MILESTONES 599PRODUCTS / TECHNOLOGIES 601RESEARCH ACTIVITIES .606AGREEMENTS .608KEY FINANCIAL DATA 609ASSOCIATED COMPANIES 609COMPETITION 609SOLIGENIX .611KEY PERSONNEL 611COMPANY OVERVIEW 611KEY MILESTONES .611PRODUCTS / TECHNOLOGIES 612RESEARCH ACTIVITIES .615AGREEMENTS .618KEY FINANCIAL DATA 619COMPETITION 619STARPHARMA . 621KEY PERSONNEL 621COMPANY OVERVIEW .621KEY MILESTONES 621PRODUCTS / TECHNOLOGIES 621RESEARCH ACTIVITIES .622AGREEMENTS .625KEY FINANCIAL DATA 626SUPRATEK PHARMA INC 627KEY PERSONNEL 627COMPANY OVERVIEW .627KEY MILESTONES 627PRODUCTS / TECHNOLOGIES 627RESEARCH ACTIVITIES .630KEY FINANCIAL DATA 630TEKMIRA PHARMACEUTICALS CORPORATION .631KEY PERSONNEL 631COMPANY OVERVIEW .631KEY MILESTONES 631PRODUCTS / TECHNOLOGIES 632RESEARCH ACTIVITIES .635AGREEMENTS .638KEY FINANCIAL DATA 640TOCAGEN 641KEY PERSONNEL 641COMPANY OVERVIEW .641PRODUCTS / TECHNOLOGIES 641RESEARCH ACTIVITIES .643AGREEMENTS .643KEY FINANCIAL DATA 643COMPETITION 643TRIMEL PHARMACEUTICALS .645KEY PERSONNEL 645COMPANY OVERVIEW .645KEY MILESTONES 645PRODUCTS / TECHNOLOGIES .645RESEARCH ACTIVITIES .647KEY FINANCIAL DATA 649COMPETITION 649UNILIFE 651KEY PERSONNEL 651COMPANY OVERVIEW .651KEY MILESTONES 651PRODUCTS / TECHNOLOGIES 652RESEARCH ACTIVITIES .653AGREEMENTS .654KEY FINANCIAL DATA 655COMPETITION 655VALEANT PHARMACEUTICALS .657KEY PERSONNEL 657COMPANY OVERVIEW .657KEY MILESTONES 657PRODUCTS / TECHNOLOGIES .658RESEARCH ACTIVITIES .662AGREEMENTS 663KEY FINANCIAL DATA 666COMPETITION 666VECTURA LTD .669KEY PERSONNEL 669COMPANY OVERVIEW .669KEY MILESTONES 669PRODUCTS / TECHNOLOGIES 670RESEARCH ACTIVITIES .672AGREEMENTS .675KEY FINANCIAL DATA 676ASSOCIATED COMPANIES 676VICAL INC 677KEY PERSONNEL 677COMPANY OVERVIEW .677KEY MILESTONES 677PRODUCTS / TECHNOLOGIES 677RESEARCH ACTIVITIES .678AGREEMENTS .681KEY FINANCIAL DATA 683VIVUS INC 685KEY PERSONNEL 685COMPANY OVERVIEW .685KEY MILESTONES 685PRODUCTS / TECHNOLOGIES 686RESEARCH ACTIVITIES .690AGREEMENTS .691KEY FINANCIAL DATA 691COMPETITION 691ZOGENIX INC 693KEY PERSONNEL 693COMPANY OVERVIEW .693KEY MILESTONES 693PRODUCTS / TECHNOLOGIES 694RESEARCH ACTIVITIES .695AGREEMENTS .696KEY FINANCIAL DATA 697ZOSANO PHARMA 699KEY PERSONNEL 699COMPANY OVERVIEW .699PRODUCTS / TECHNOLOGIES 699RESEARCH ACTIVITIES .700AGREEMENTS .701KEY FINANCIAL DATA 701

To order this report: Drug_Delivery_Technology Industry: Drug Delivery: Surveying the Global Competitive Landscape

__________________________Contact Clare: clare@reportlinker.comUS:(339) 368 6001Intl:+1 339 368 6001

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,079.27 +49.06 0.27%
S&P 500 2,089.86 +7.98 0.38%
NASDAQ 4,802.2370 +28.7650 0.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs